Selected research
Industry Research
Blood Pressure Medications Industry Research Report 2026
Market perspective
The global Blood Pressure Medications market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Blood Pressure Medications is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Blood Pressure Medications is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Blood Pressure Medications is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Blood Pressure Medications include Chengdu Easton Biopharmaceuticals, CSPC Pharmaceutical Group, Shanghai Shyndec Pharmaceutical, Sanofi, Qingdao Huanghai Pharmaceutical, Novartis, Merck, Jiangsu Jibeier Pharmaceutical and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Blood Pressure Medications market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Blood Pressure Medications Market by Company
Chengdu Easton Biopharmaceuticals
CSPC Pharmaceutical Group
Shanghai Shyndec Pharmaceutical
Sanofi
Qingdao Huanghai Pharmaceutical
Novartis
Merck
Jiangsu Jibeier Pharmaceutical
Pfizer
CR Double-Crane
Huahai Pharmaceutical
Jiangsu Hengrui Medicine
Tianjin Pharmaceutical Da Ren Tang Group
Boehringer Ingelheim
Bayer
AstraZeneca
Lupin Pharmaceuticals
Blood Pressure Medications Segment by Type
Angiotensin II Receptor Blockers
Diuretics
Calcium Channel Blockers
Compound Drugs
Beta Blockers
ACE Inhibitors
Others
Blood Pressure Medications Segment by Application
Hospital
Clinic
Others
Blood Pressure Medications Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Pressure Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Pressure Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Pressure Medications.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Blood Pressure Medications manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Blood Pressure Medications by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Blood Pressure Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Blood Pressure Medications Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Blood Pressure Medications Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Blood Pressure Medications Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Blood Pressure Medications Revenue of Manufacturers (2021-2026)
Table 9. Global Blood Pressure Medications Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Blood Pressure Medications Average Price (US$/unit) of Manufacturers (2021-2026)
Table 11. Global Blood Pressure Medications Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Blood Pressure Medications, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Blood Pressure Medications, Product Type & Application
Table 14. Global Blood Pressure Medications Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Blood Pressure Medications by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Chengdu Easton Biopharmaceuticals Company Information
Table 19. Chengdu Easton Biopharmaceuticals Business Overview
Table 20. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 21. Chengdu Easton Biopharmaceuticals Blood Pressure Medications Product Portfolio
Table 22. Chengdu Easton Biopharmaceuticals Recent Developments
Table 23. CSPC Pharmaceutical Group Company Information
Table 24. CSPC Pharmaceutical Group Business Overview
Table 25. CSPC Pharmaceutical Group Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 26. CSPC Pharmaceutical Group Blood Pressure Medications Product Portfolio
Table 27. CSPC Pharmaceutical Group Recent Developments
Table 28. Shanghai Shyndec Pharmaceutical Company Information
Table 29. Shanghai Shyndec Pharmaceutical Business Overview
Table 30. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 31. Shanghai Shyndec Pharmaceutical Blood Pressure Medications Product Portfolio
Table 32. Shanghai Shyndec Pharmaceutical Recent Developments
Table 33. Sanofi Company Information
Table 34. Sanofi Business Overview
Table 35. Sanofi Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 36. Sanofi Blood Pressure Medications Product Portfolio
Table 37. Sanofi Recent Developments
Table 38. Qingdao Huanghai Pharmaceutical Company Information
Table 39. Qingdao Huanghai Pharmaceutical Business Overview
Table 40. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 41. Qingdao Huanghai Pharmaceutical Blood Pressure Medications Product Portfolio
Table 42. Qingdao Huanghai Pharmaceutical Recent Developments
Table 43. Novartis Company Information
Table 44. Novartis Business Overview
Table 45. Novartis Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 46. Novartis Blood Pressure Medications Product Portfolio
Table 47. Novartis Recent Developments
Table 48. Merck Company Information
Table 49. Merck Business Overview
Table 50. Merck Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 51. Merck Blood Pressure Medications Product Portfolio
Table 52. Merck Recent Developments
Table 53. Jiangsu Jibeier Pharmaceutical Company Information
Table 54. Jiangsu Jibeier Pharmaceutical Business Overview
Table 55. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 56. Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Product Portfolio
Table 57. Jiangsu Jibeier Pharmaceutical Recent Developments
Table 58. Pfizer Company Information
Table 59. Pfizer Business Overview
Table 60. Pfizer Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 61. Pfizer Blood Pressure Medications Product Portfolio
Table 62. Pfizer Recent Developments
Table 63. CR Double-Crane Company Information
Table 64. CR Double-Crane Business Overview
Table 65. CR Double-Crane Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 66. CR Double-Crane Blood Pressure Medications Product Portfolio
Table 67. CR Double-Crane Recent Developments
Table 68. Huahai Pharmaceutical Company Information
Table 69. Huahai Pharmaceutical Business Overview
Table 70. Huahai Pharmaceutical Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 71. Huahai Pharmaceutical Blood Pressure Medications Product Portfolio
Table 72. Huahai Pharmaceutical Recent Developments
Table 73. Jiangsu Hengrui Medicine Company Information
Table 74. Jiangsu Hengrui Medicine Business Overview
Table 75. Jiangsu Hengrui Medicine Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 76. Jiangsu Hengrui Medicine Blood Pressure Medications Product Portfolio
Table 77. Jiangsu Hengrui Medicine Recent Developments
Table 78. Tianjin Pharmaceutical Da Ren Tang Group Company Information
Table 79. Tianjin Pharmaceutical Da Ren Tang Group Business Overview
Table 80. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 81. Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Product Portfolio
Table 82. Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
Table 83. Boehringer Ingelheim Company Information
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 86. Boehringer Ingelheim Blood Pressure Medications Product Portfolio
Table 87. Boehringer Ingelheim Recent Developments
Table 88. Bayer Company Information
Table 89. Bayer Business Overview
Table 90. Bayer Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 91. Bayer Blood Pressure Medications Product Portfolio
Table 92. Bayer Recent Developments
Table 93. AstraZeneca Company Information
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 96. AstraZeneca Blood Pressure Medications Product Portfolio
Table 97. AstraZeneca Recent Developments
Table 98. Lupin Pharmaceuticals Company Information
Table 99. Lupin Pharmaceuticals Business Overview
Table 100. Lupin Pharmaceuticals Blood Pressure Medications Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026)
Table 101. Lupin Pharmaceuticals Blood Pressure Medications Product Portfolio
Table 102. Lupin Pharmaceuticals Recent Developments
Table 103. Global Blood Pressure Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 104. Global Blood Pressure Medications Sales by Region (2021-2026) & (k units)
Table 105. Global Blood Pressure Medications Sales Market Share by Region (2021-2026)
Table 106. Global Blood Pressure Medications Sales by Region (2027-2032) & (k units)
Table 107. Global Blood Pressure Medications Sales Market Share by Region (2027-2032)
Table 108. Global Blood Pressure Medications Revenue by Region (2021-2026) & (US$ Million)
Table 109. Global Blood Pressure Medications Revenue Market Share by Region (2021-2026)
Table 110. Global Blood Pressure Medications Revenue by Region (2027-2032) & (US$ Million)
Table 111. Global Blood Pressure Medications Revenue Market Share by Region (2027-2032)
Table 112. North America Blood Pressure Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. North America Blood Pressure Medications Sales by Country (2021-2026) & (k units)
Table 114. North America Blood Pressure Medications Sales by Country (2027-2032) & (k units)
Table 115. North America Blood Pressure Medications Revenue by Country (2021-2026) & (US$ Million)
Table 116. North America Blood Pressure Medications Revenue by Country (2027-2032) & (US$ Million)
Table 117. Europe Blood Pressure Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Europe Blood Pressure Medications Sales by Country (2021-2026) & (k units)
Table 119. Europe Blood Pressure Medications Sales by Country (2027-2032) & (k units)
Table 120. Europe Blood Pressure Medications Revenue by Country (2021-2026) & (US$ Million)
Table 121. Europe Blood Pressure Medications Revenue by Country (2027-2032) & (US$ Million)
Table 122. Asia Pacific Blood Pressure Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Asia Pacific Blood Pressure Medications Sales by Country (2021-2026) & (k units)
Table 124. Asia Pacific Blood Pressure Medications Sales by Country (2027-2032) & (k units)
Table 125. Asia Pacific Blood Pressure Medications Revenue by Country (2021-2026) & (US$ Million)
Table 126. Asia Pacific Blood Pressure Medications Revenue by Country (2027-2032) & (US$ Million)
Table 127. South America Blood Pressure Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. South America Blood Pressure Medications Sales by Country (2021-2026) & (k units)
Table 129. South America Blood Pressure Medications Sales by Country (2027-2032) & (k units)
Table 130. South America Blood Pressure Medications Revenue by Country (2021-2026) & (US$ Million)
Table 131. South America Blood Pressure Medications Revenue by Country (2027-2032) & (US$ Million)
Table 132. Middle East and Africa Blood Pressure Medications Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Middle East and Africa Blood Pressure Medications Sales by Country (2021-2026) & (k units)
Table 134. Middle East and Africa Blood Pressure Medications Sales by Country (2027-2032) & (k units)
Table 135. Middle East and Africa Blood Pressure Medications Revenue by Country (2021-2026) & (US$ Million)
Table 136. Middle East and Africa Blood Pressure Medications Revenue by Country (2027-2032) & (US$ Million)
Table 137. Global Blood Pressure Medications Sales by Type (2021-2026) & (k units)
Table 138. Global Blood Pressure Medications Sales by Type (2027-2032) & (k units)
Table 139. Global Blood Pressure Medications Sales Market Share by Type (2021-2026)
Table 140. Global Blood Pressure Medications Sales Market Share by Type (2027-2032)
Table 141. Global Blood Pressure Medications Revenue by Type (2021-2026) & (US$ Million)
Table 142. Global Blood Pressure Medications Revenue by Type (2027-2032) & (US$ Million)
Table 143. Global Blood Pressure Medications Revenue Market Share by Type (2021-2026)
Table 144. Global Blood Pressure Medications Revenue Market Share by Type (2027-2032)
Table 145. Global Blood Pressure Medications Price by Type (2021-2026) & (US$/unit)
Table 146. Global Blood Pressure Medications Price by Type (2027-2032) & (US$/unit)
Table 147. Global Blood Pressure Medications Sales by Application (2021-2026) & (k units)
Table 148. Global Blood Pressure Medications Sales by Application (2027-2032) & (k units)
Table 149. Global Blood Pressure Medications Sales Market Share by Application (2021-2026)
Table 150. Global Blood Pressure Medications Sales Market Share by Application (2027-2032)
Table 151. Global Blood Pressure Medications Revenue by Application (2021-2026) & (US$ Million)
Table 152. Global Blood Pressure Medications Revenue by Application (2027-2032) & (US$ Million)
Table 153. Global Blood Pressure Medications Revenue Market Share by Application (2021-2026)
Table 154. Global Blood Pressure Medications Revenue Market Share by Application (2027-2032)
Table 155. Global Blood Pressure Medications Price by Application (2021-2026) & (US$/unit)
Table 156. Global Blood Pressure Medications Price by Application (2027-2032) & (US$/unit)
Table 157. Key Raw Materials
Table 158. Raw Materials Key Suppliers
Table 159. Blood Pressure Medications Distributors List
Table 160. Blood Pressure Medications Customers List
Table 161. Blood Pressure Medications Industry Trends
Table 162. Blood Pressure Medications Industry Drivers
Table 163. Blood Pressure Medications Industry Restraints
Table 164. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Blood Pressure Medications Product Image
Figure 5. Global Blood Pressure Medications Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Blood Pressure Medications Market Size (2021-2032) & (US$ Million)
Figure 7. Global Blood Pressure Medications Sales (2021-2032) & (k units)
Figure 8. Global Blood Pressure Medications Average Price (US$/unit) & (2021-2032)
Figure 9. Angiotensin II Receptor Blockers Product Image
Figure 10. Diuretics Product Image
Figure 11. Calcium Channel Blockers Product Image
Figure 12. Compound Drugs Product Image
Figure 13. Beta Blockers Product Image
Figure 14. ACE Inhibitors Product Image
Figure 15. Others Product Image
Figure 16. Hospital Product Image
Figure 17. Clinic Product Image
Figure 18. Others Product Image
Figure 19. Global Blood Pressure Medications Revenue Share by Manufacturers in 2025
Figure 20. Global Manufacturers of Blood Pressure Medications, Manufacturing Sites & Headquarters
Figure 21. Global Top 5 and 10 Blood Pressure Medications Players Market Share by Revenue in 2025
Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Global Blood Pressure Medications Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 24. Global Blood Pressure Medications Sales by Region in 2025
Figure 25. Global Blood Pressure Medications Revenue by Region in 2025
Figure 26. North America Blood Pressure Medications Market Size by Country in 2025
Figure 27. North America Blood Pressure Medications Sales Market Share by Country (2021-2032)
Figure 28. North America Blood Pressure Medications Revenue Market Share by Country (2021-2032)
Figure 29. United States Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Canada Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Mexico Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Europe Blood Pressure Medications Market Size by Country in 2025
Figure 33. Europe Blood Pressure Medications Sales Market Share by Country (2021-2032)
Figure 34. Europe Blood Pressure Medications Revenue Market Share by Country (2021-2032)
Figure 35. Germany Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. France Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. U.K. Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Italy Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Russia Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Spain Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Netherlands Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Switzerland Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Sweden Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Poland Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Asia Pacific Blood Pressure Medications Market Size by Country in 2025
Figure 46. Asia Pacific Blood Pressure Medications Sales Market Share by Country (2021-2032)
Figure 47. Asia Pacific Blood Pressure Medications Revenue Market Share by Country (2021-2032)
Figure 48. China Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Japan Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South Korea Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. India Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Australia Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Taiwan Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Southeast Asia Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Southeast Asia Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. South America Blood Pressure Medications Market Size by Country in 2025
Figure 57. South America Blood Pressure Medications Sales Market Share by Country (2021-2032)
Figure 58. South America Blood Pressure Medications Revenue Market Share by Country (2021-2032)
Figure 59. Brazil Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Argentina Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Chile Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Middle East and Africa Blood Pressure Medications Market Size by Country in 2025
Figure 63. Middle East and Africa Blood Pressure Medications Sales Market Share by Country (2021-2032)
Figure 64. Middle East and Africa Blood Pressure Medications Revenue Market Share by Country (2021-2032)
Figure 65. Egypt Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. South Africa Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Israel Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. Türkiye Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 69. GCC Countries Blood Pressure Medications Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 70. Global Blood Pressure Medications Sales Market Share by Type (2021-2032)
Figure 71. Global Blood Pressure Medications Revenue Market Share by Type (2021-2032)
Figure 72. Global Blood Pressure Medications Price (US$/unit) by Type (2021-2032)
Figure 73. Global Blood Pressure Medications Sales Market Share by Application (2021-2032)
Figure 74. Global Blood Pressure Medications Revenue Market Share by Application (2021-2032)
Figure 75. Global Blood Pressure Medications Price (US$/unit) by Application (2021-2032)
Figure 76. Blood Pressure Medications Value Chain
Figure 77. Blood Pressure Medications Production Mode & Process
Figure 78. Direct Comparison with Distribution Share
Figure 79. Distributors Profiles
Figure 80. Blood Pressure Medications Industry Opportunities and Challenges
Scope & coverage.
Types
- Angiotensin II Receptor Blockers
- Diuretics
- Calcium Channel Blockers
- Compound Drugs
- Beta Blockers
- ACE Inhibitors
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Chengdu Easton Biopharmaceuticals
- CSPC Pharmaceutical Group
- Shanghai Shyndec Pharmaceutical
- Sanofi
- Qingdao Huanghai Pharmaceutical
- Novartis
- Merck
- Jiangsu Jibeier Pharmaceutical
- Pfizer
- CR Double-Crane
- Huahai Pharmaceutical
- Jiangsu Hengrui Medicine
- Tianjin Pharmaceutical Da Ren Tang Group
- Boehringer Ingelheim
- Bayer
- AstraZeneca
- Lupin Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Blood Pressure Medications Market Size (2021-2032)
- 2.2.2 Global Blood Pressure Medications Sales (2021-2032)
- 2.2.3 Global Blood Pressure Medications Market Average Price (2021-2032)
- 2.3 Blood Pressure Medications by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Angiotensin II Receptor Blockers
- 2.3.3 Diuretics
- 2.3.4 Calcium Channel Blockers
- 2.3.5 Compound Drugs
- 2.3.6 Beta Blockers
- 2.3.7 ACE Inhibitors
- 2.3.8 Others
- 2.4 Blood Pressure Medications by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Blood Pressure Medications Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Blood Pressure Medications Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Blood Pressure Medications Revenue of Manufacturers (2021-2026)
- 3.4 Global Blood Pressure Medications Average Price by Manufacturers (2021-2026)
- 3.5 Global Blood Pressure Medications Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Blood Pressure Medications, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Blood Pressure Medications, Product Type & Application
- 3.8 Global Manufacturers of Blood Pressure Medications, Established Date
- 3.9 Global Blood Pressure Medications Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chengdu Easton Biopharmaceuticals
- 4.1.1 Chengdu Easton Biopharmaceuticals Company Information
- 4.1.2 Chengdu Easton Biopharmaceuticals Business Overview
- 4.1.3 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chengdu Easton Biopharmaceuticals Blood Pressure Medications Product Portfolio
- 4.1.5 Chengdu Easton Biopharmaceuticals Recent Developments
- 4.2 CSPC Pharmaceutical Group
- 4.2.1 CSPC Pharmaceutical Group Company Information
- 4.2.2 CSPC Pharmaceutical Group Business Overview
- 4.2.3 CSPC Pharmaceutical Group Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSPC Pharmaceutical Group Blood Pressure Medications Product Portfolio
- 4.2.5 CSPC Pharmaceutical Group Recent Developments
- 4.3 Shanghai Shyndec Pharmaceutical
- 4.3.1 Shanghai Shyndec Pharmaceutical Company Information
- 4.3.2 Shanghai Shyndec Pharmaceutical Business Overview
- 4.3.3 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Shyndec Pharmaceutical Blood Pressure Medications Product Portfolio
- 4.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
- 4.4 Sanofi
- 4.4.1 Sanofi Company Information
- 4.4.2 Sanofi Business Overview
- 4.4.3 Sanofi Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sanofi Blood Pressure Medications Product Portfolio
- 4.4.5 Sanofi Recent Developments
- 4.5 Qingdao Huanghai Pharmaceutical
- 4.5.1 Qingdao Huanghai Pharmaceutical Company Information
- 4.5.2 Qingdao Huanghai Pharmaceutical Business Overview
- 4.5.3 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Qingdao Huanghai Pharmaceutical Blood Pressure Medications Product Portfolio
- 4.5.5 Qingdao Huanghai Pharmaceutical Recent Developments
- 4.6 Novartis
- 4.6.1 Novartis Company Information
- 4.6.2 Novartis Business Overview
- 4.6.3 Novartis Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Novartis Blood Pressure Medications Product Portfolio
- 4.6.5 Novartis Recent Developments
- 4.7 Merck
- 4.7.1 Merck Company Information
- 4.7.2 Merck Business Overview
- 4.7.3 Merck Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merck Blood Pressure Medications Product Portfolio
- 4.7.5 Merck Recent Developments
- 4.8 Jiangsu Jibeier Pharmaceutical
- 4.8.1 Jiangsu Jibeier Pharmaceutical Company Information
- 4.8.2 Jiangsu Jibeier Pharmaceutical Business Overview
- 4.8.3 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jiangsu Jibeier Pharmaceutical Blood Pressure Medications Product Portfolio
- 4.8.5 Jiangsu Jibeier Pharmaceutical Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Blood Pressure Medications Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 CR Double-Crane
- 4.10.1 CR Double-Crane Company Information
- 4.10.2 CR Double-Crane Business Overview
- 4.10.3 CR Double-Crane Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CR Double-Crane Blood Pressure Medications Product Portfolio
- 4.10.5 CR Double-Crane Recent Developments
- 4.11 Huahai Pharmaceutical
- 4.11.1 Huahai Pharmaceutical Company Information
- 4.11.2 Huahai Pharmaceutical Business Overview
- 4.11.3 Huahai Pharmaceutical Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Huahai Pharmaceutical Blood Pressure Medications Product Portfolio
- 4.11.5 Huahai Pharmaceutical Recent Developments
- 4.12 Jiangsu Hengrui Medicine
- 4.12.1 Jiangsu Hengrui Medicine Company Information
- 4.12.2 Jiangsu Hengrui Medicine Business Overview
- 4.12.3 Jiangsu Hengrui Medicine Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Jiangsu Hengrui Medicine Blood Pressure Medications Product Portfolio
- 4.12.5 Jiangsu Hengrui Medicine Recent Developments
- 4.13 Tianjin Pharmaceutical Da Ren Tang Group
- 4.13.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
- 4.13.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
- 4.13.3 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Tianjin Pharmaceutical Da Ren Tang Group Blood Pressure Medications Product Portfolio
- 4.13.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
- 4.14 Boehringer Ingelheim
- 4.14.1 Boehringer Ingelheim Company Information
- 4.14.2 Boehringer Ingelheim Business Overview
- 4.14.3 Boehringer Ingelheim Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Boehringer Ingelheim Blood Pressure Medications Product Portfolio
- 4.14.5 Boehringer Ingelheim Recent Developments
- 4.15 Bayer
- 4.15.1 Bayer Company Information
- 4.15.2 Bayer Business Overview
- 4.15.3 Bayer Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Bayer Blood Pressure Medications Product Portfolio
- 4.15.5 Bayer Recent Developments
- 4.16 AstraZeneca
- 4.16.1 AstraZeneca Company Information
- 4.16.2 AstraZeneca Business Overview
- 4.16.3 AstraZeneca Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 AstraZeneca Blood Pressure Medications Product Portfolio
- 4.16.5 AstraZeneca Recent Developments
- 4.17 Lupin Pharmaceuticals
- 4.17.1 Lupin Pharmaceuticals Company Information
- 4.17.2 Lupin Pharmaceuticals Business Overview
- 4.17.3 Lupin Pharmaceuticals Blood Pressure Medications Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Lupin Pharmaceuticals Blood Pressure Medications Product Portfolio
- 4.17.5 Lupin Pharmaceuticals Recent Developments
5 Global Blood Pressure Medications Market Scenario by Region
- 5.1 Global Blood Pressure Medications Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Blood Pressure Medications Sales by Region: 2021-2032
- 5.2.1 Global Blood Pressure Medications Sales by Region: 2021-2026
- 5.2.2 Global Blood Pressure Medications Sales by Region: 2027-2032
- 5.3 Global Blood Pressure Medications Revenue by Region: 2021-2032
- 5.3.1 Global Blood Pressure Medications Revenue by Region: 2021-2026
- 5.3.2 Global Blood Pressure Medications Revenue by Region: 2027-2032
- 5.4 North America Blood Pressure Medications Market Facts & Figures by Country
- 5.4.1 North America Blood Pressure Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Blood Pressure Medications Sales by Country (2021-2032)
- 5.4.3 North America Blood Pressure Medications Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Blood Pressure Medications Market Facts & Figures by Country
- 5.5.1 Europe Blood Pressure Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Blood Pressure Medications Sales by Country (2021-2032)
- 5.5.3 Europe Blood Pressure Medications Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Blood Pressure Medications Market Facts & Figures by Country
- 5.6.1 Asia Pacific Blood Pressure Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Blood Pressure Medications Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Blood Pressure Medications Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Blood Pressure Medications Market Facts & Figures by Country
- 5.7.1 South America Blood Pressure Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Blood Pressure Medications Sales by Country (2021-2032)
- 5.7.3 South America Blood Pressure Medications Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Blood Pressure Medications Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Blood Pressure Medications Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Blood Pressure Medications Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Blood Pressure Medications Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Blood Pressure Medications Sales by Type (2021-2032)
- 6.1.1 Global Blood Pressure Medications Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Blood Pressure Medications Sales Market Share by Type (2021-2032)
- 6.2 Global Blood Pressure Medications Revenue by Type (2021-2032)
- 6.2.1 Global Blood Pressure Medications Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Blood Pressure Medications Revenue Market Share by Type (2021-2032)
- 6.3 Global Blood Pressure Medications Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Blood Pressure Medications Sales by Application (2021-2032)
- 7.1.1 Global Blood Pressure Medications Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Blood Pressure Medications Sales Market Share by Application (2021-2032)
- 7.2 Global Blood Pressure Medications Revenue by Application (2021-2032)
- 7.2.1 Global Blood Pressure Medications Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Blood Pressure Medications Revenue Market Share by Application (2021-2032)
- 7.3 Global Blood Pressure Medications Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Blood Pressure Medications Value Chain Analysis
- 8.1.1 Blood Pressure Medications Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Blood Pressure Medications Production Mode & Process
- 8.2 Blood Pressure Medications Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Blood Pressure Medications Distributors
- 8.2.3 Blood Pressure Medications Customers
9 Global Blood Pressure Medications Analyzing Market Dynamics
- 9.1 Blood Pressure Medications Industry Trends
- 9.2 Blood Pressure Medications Industry Drivers
- 9.3 Blood Pressure Medications Industry Opportunities and Challenges
- 9.4 Blood Pressure Medications Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst